CSL Limited Unveils Major Strategic Transformation for Sustainable Growth - TipRanks
TipRanksarrow_outwardCSL to Spin Off Vaccine Unit Seqirus, Plans $487 Million Buyback
Bloombergarrow_outwardCSL Posts Fiscal 2025 EPS of $0.0617, Total Operating Revenue of $15.56 Billion
MarketScreenerarrow_outwardAustralian biopharma firm CSL posts 14% rise in annual profit
MSNarrow_outwardCSL's Strategic Restructuring and Share Buyback Signal Value Opportunity in Biotech Sector - AInvest
AInvestarrow_outwardBefore the Bell: ASX to open lower, Powell speech awaited - AFR
AFRarrow_outwardCSL to spin off influenza vaccine unit, flags job cuts and share buyback - TradingView
TradingViewarrow_outwardCSL to Spin Off Vaccine Unit Seqirus, Plans $487 Million Buyback - Bloomberg.com
Bloomberg.comarrow_outwardLive: ASX set to fall as Economic Reform Roundtable begins, US stocks lift on interest rate cut hopes - Australian Broadcasting Corporation
Australian Broadcasting Corporationarrow_outwardBHP, CSL earnings in focus; Trump weighs Intel stake buy - Herald Sun
Herald Sunarrow_outwardCSL Limited Sponsored ADR (OTCMKTS:CSLLY) Short Interest Update - MarketBeat
MarketBeatarrow_outwardBHP in focus; CSL flags Seqirus demerger, $750m buyback - The Australian
The Australianarrow_outwardCSL share price: why investors like healthcare shares - Rask Media
Rask Mediaarrow_outwardMiss the trade and helplessly watch this stock’s breakaway run - The Courier Mail
The Courier Mailarrow_outwardVideo: BMW M4 CSL Test Reveals Lap Times, Weight, and Surprising MPG - BMW Blog
BMW Blogarrow_outwardHow Investors May Respond To CSL (ASX:CSL) Gaining Canadian Approval for ANDEMBRY in Rare Disease Market - simplywall.st
Simplywall.starrow_outwardCSL, Telix lead biotech selloff after Eli Lilly tanks on Wall Street - Capital Brief
Capital Briefarrow_outwardCSL downgraded to Hold - intelligentinvestor.com.au
Intelligentinvestor.com.auarrow_outwardWhy CSL shares are a buy today despite the looming Trump tariffs - The Motley Fool Australia
The Motley Fool Australiaarrow_outwardCSL Shares Surge to Multi-Month High - Sharecafe
Sharecafearrow_outwardScoPo’s Powerplays: CSL leads a 5pc ASX health stocks rally - Stockhead
Stockheadarrow_outwardHow Trump’s Proposed 200% Tariffs Could Hit CSL (ASX:CSL) and Other Aussie Biotechs - Stocks Down Under
Stocks Down Underarrow_outwardAustralia’s CSL hits 6-wk high on report of R&D division job cuts - Investing.com Australia
Investing.com Australiaarrow_outwardAustralia’s CSL hits 6-wk high on report of R&D division job cuts - Investing.com
Investing.comarrow_outwardCSL Shares (ASX: CSL) Under Pressure Looking For Support - thebull.com.au
Thebull.com.auarrow_outwardMary Oates - Global Biotechnology Company
Global Biotechnology Companyarrow_outwardThe ASX EOFY fire sale: CSL and 4 other stocks on a big discount - Livewire Markets
Livewire Marketsarrow_outwardWhat the hell, CSL: is this big Aussie pharma about to storm back? - Switzer Daily
Switzer Dailyarrow_outwardCSL Behring’s Victorian facility wins global pharmaceutical manufacturing award - BioMelbourne Network
BioMelbourne Networkarrow_outwardWhy have CSL and WiseTech Global remained resilient despite trade tensions? - ig.com
Ig.comarrow_outwardIs CSL undervalued after earnings season wobble? - Morningstar
Morningstararrow_outwardImmunoglobulin sales drive a strong first half for CSL - Biotech Dispatch
Biotech Dispatcharrow_outward
Csl close
- 2025-08-19 06:10 event
- 32 sourceslanguage
- 100+ ads_click
- 1 week ago schedule